Search

everythinglearnresearchcommunity

for

Search:↓

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Low-level light therapy safely increases hair growth in various types of hair loss.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

New medications could improve treatment for severe alopecia areata in Australia.

Females have a higher lifetime risk of alopecia areata than males.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Exosome therapy successfully regrew and restored natural hair color in a man with stress-related hair loss.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

COVID-19 vaccines do not increase the risk of alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Pertussis toxin may contribute to hair loss in alopecia areata.